Over-the-Counter Drugs Market to hit $178bn by 2024: Global Market Insights, Inc.
03 janv. 2018 02h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Global OTC Drugs Market is estimated to surpass USD 178 billion by 2024; according to a new research report by Global Market Insights....
Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability
28 déc. 2017 09h00 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and...
RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.
13 sept. 2017 07h00 HE
|
RedHill Biopharma Ltd.
Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux...
Innovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan Designation
06 sept. 2017 17h06 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory...
Innovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis Indication
12 juil. 2017 07h07 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., July 12, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory...
Innovate Biopharmaceuticals to present progress towards phase 3 celiac disease trials at BIO 2017 Convention
06 juin 2017 08h07 HE
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, a leader in developing innovative therapies for autoimmune and inflammatory diseases, will present on its phase 3 drug...
A Microbiologist's Approach to Identifying & Avoiding Food Poisoning
02 févr. 2016 15h34 HE
|
ARUP Laboratories
SALT LAKE CITY, Feb. 2, 2016 (GLOBE NEWSWIRE) -- Chipotle is in the midst of a restaurant's nightmare, as it contends with the consequences of three major foodborne outbreaks this past year involving...
RedHill Biopharma to Host 2014 Fourth Quarter and Year-End Financial Results Conference Call on February 26, 2015
19 févr. 2015 08h00 HE
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, Feb. 19, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...
RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
13 févr. 2015 10h18 HE
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
03 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...